Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × binimetinib × Breast × Clear all

Phase

Status

Completed 3 Terminated 1 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 7 CNS 4 Gastrointestinal 3 Other hematologic neoplasm 2 Thoracic 1 Other solid neoplasm 1 Head & Neck 1 Gynecologic 1 Breast 1

Conditions

Triple Negative Breast Neoplasms 1 Breast Neoplasms 1

Interventions

pembrolizumab 69 Fulvestrant 64 Carboplatin 59 Trastuzumab 57 Capecitabine 56 Letrozole 53 Specimen Handling 50 Paclitaxel 49 Cyclophosphamide 49 Docetaxel 46 ribociclib 41 pertuzumab 39 abemaciclib 39 Magnetic Resonance Spectroscopy 34 trastuzumab deruxtecan 33 Blood Specimen Collection 31 130-nm albumin-bound paclitaxel 30 Biopsy 29 Anastrozole 29 sacituzumab govitecan 27 Tamoxifen 27 Surveys and Questionnaires 26 pyrotinib 24 Injections 24 palbociclib 23 Radiotherapy 23 Drug Therapy 23 exemestane 22 Gemcitabine 21 Epirubicin 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03971409 2025-05-02

InCITe

University of California, San Francisco

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡